CNTX stock news · Context Therapeutics Inc.
Get alerts for CNTX
Follow Context Therapeutics Inc. (CNTX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CNTXFree on the App Store and Google Play, or on the web.
Context Therapeutics shared its third quarter 2026 results and updates on its projects.
NeutralCNTX filed a report announcing third-quarter 2026 results and pipeline updates, but gives no figures or specific pipeline changes. This text does not change how we read the company.
12 health care companies are changing a lot in Friday's early trading.
NeutralContext Therapeutics' shares fell about 10% to $0.21 in Friday's pre-market session. The report gives no company update, so the move alone does not change Context Therapeutics' business outlook.